Cationic liposome-mediated delivery of reovirus enhances the tumor cell-killing efficiencies of reovirus in reovirus-resistant tumor cells

F Sakurai, S Inoue, T Kaminade, T Hotani… - International Journal of …, 2017 - Elsevier
Reovirus induces tumor cell death efficiently and specifically, and thus is currently undergoing
clinical testing as an anticancer agent. In the intracellular trafficking of reovirus, proteolytic …

A TGFβ Signaling Inhibitor, SB431542, inhibits reovirus-mediated lysis of human hepatocellular carcinoma cells in a TGFβ-independent Manner

I Ishigami, N Shuwari, T Kaminade… - Anticancer …, 2021 - ar.iiarjournals.org
Background/Aim: Oncolytic reovirus, which is a non-enveloped virus possessing a 10-segmented
double-stranded RNA genome, has been anticipated as a novel class of antitumor …

Oncolytic reovirus-mediated killing of mouse cancer-associated fibroblasts

N Kurisu, T Kaminade, M Eguchi, I Ishigami… - International Journal of …, 2021 - Elsevier
Oncolytic viruses, which mediate tumor cell-specific infection, resulting in efficient tumor cell
killing, have attracted much attention as a novel class of anti-cancer biopharmaceutical …

Risk-Benefit Analysis of Solid Tumor vs. Blood/Metastatic Cancer Treatment with Reovirus

Y Kettoola - 2017 - search.proquest.com
In the past several years, cancer treatments using FDA approved immune checkpoint inhibitors
have become more popular than common chemotherapeutic agents. However, the costs, …

[CITATION][C] NBT CARRON ATOM m FROM 5, 6-(9', lC% DIHYRCWlCF-Abfl% RA~ O)-1, &4, 6-CY~ HEPTATEIlbWW TJ McCarthy, D. C Pang, S. Tivakompanna& and …

A New